Inhibition of production of macrophage-derived angiogenic activity by the anti-rheumatic agents gold sodium thiomalate and auranofin.
We have investigated the effect of gold sodium thiomalate and auranofin, gold compounds employed in the treatment of rheumatoid arthritis, on production of macrophage-derived angiogenic activity. Elicited mouse peritoneal macrophages were cultured in the presence or absence of gold compounds or thiomalic acid, and the macrophages or their conditioned media were then assayed for their angiogenic activity in rat corneas. Control macrophage conditioned medium was potently angiogenic. In contrast, conditioned medium from gold or thiomalic acid treated macrophages was not. Addition of gold compounds or thiomalic acid to control macrophage conditioned medium did not inhibit its angiogenic activity. Drug treatments did not significantly affect macrophage lactate dehydrogenase release, lysozyme release, or protein synthesis. We conclude that gold sodium thiomalate and auranofin potently reduce the detectable angiogenic activity produced by macrophages.
Koch
A E
AE
Department of Medicine, Northwestern University Medical and Dental Schools, Chicago, IL.
Cho
M
M
Burrows
J
J
Leibovich
S J
SJ
Polverini
P J
PJ
D000818:Animals; D001310:Auranofin / Q000494:pharmacology*; D001681:Biological Assay; D002478:Cells, Cultured; D003315:Cornea / Q000098:blood supply; D006052:Gold Sodium Thiomalate / Q000494:pharmacology*; D008070:Lipopolysaccharides / Q000494:pharmacology; D008264:Macrophages / Q000187:drug effects / Q000502:physiology*; D051379:Mice; D008807:Mice, Inbred BALB C; D009113:Muramidase / Q000378:metabolism; D009389:Neovascularization, Pathologic; D014176:Protein Biosynthesis; D051381:Rats; D012016:Reference Values
D008070:Lipopolysaccharides; D006052:Gold Sodium Thiomalate; D001310:Auranofin; D009113:Muramidase